Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the pharmacokinetics, safety, and tolerability of Cabotegravir Ultra Long-acting (CAB ULA) after switching from Cabotegravir Long-acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cabotegravir Ultra Long-acting (cabotegravir ultra-long-acting formulation)
• Cabotegravir long-acting (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: ACTIVE_NOT_RECRUITING